An advance that seemed like science fiction just a few years ago has just become a reality with the French company Wondercraftreceiving the second FDA approval for its Atalante X exoskeleton. It is a historic milestone that expands the use of this technology and redefines what is possible in terms of rehabilitation and human movement.

With a self-balancing design and powered by artificial intelligence, Atalante X allows people with total or partial paralysis to stand, walk and move again without the need for crutches or manual support. The approval comes a few months after the European CE certification and represents global recognition of the effectiveness and safety of the system.

The system can now be used in cases ranging from spinal cord selections between S4 and L5 to stroke and multiple sclerosis, dramatically expanding access to upright walking therapy. The secret is in the fusion between robotic and adaptive engineering, trained with billions of simulations and millions of steps in real environments, Atalante X learns to adjust force, rhythm and balance in real time, offering independent support for hips and knees, this allows precise control and closer to natural movement, simulating the biomechanics of human walking.

Today more than 100 rehabilitation and research centers around the world already use the exoskeleton with patients taking more than a million steps per month; Wondercraft has also raised $75 million in its 7D round to expand production and prepare for the launch of a personal version of the exoskeleton aimed at everyday independence.

For millions of people who have lost mobility due to ACB injuries or degenerative diseases, Atalante X represents more than a medical device, it is the promise of recovering movement, autonomy and dignity and perhaps the first step towards a new era in which robotics not only imitates the human body, but gives life back to all those people with serious injuries.